Fry, Terry J.
Children's Hospital Colorado · National Cancer Institute · Center for Cancer Research · University of Colorado Anschutz
13 papers on CoChatORCID 0000-0001-8044-5226
Most cited papers
- Verified
T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial
Lee, D. W., Kochenderfer, J. N., Stetler-Stevenson, M., Cui, Y. K., Delbrook, C., Feldman, S. A., Fry, T. J., Orentas, R., Sabatino, M., Shah, N. N., et al. (2015) · The Lancet
CAR-T cell therapy researchAcute Lymphoblastic Leukemia research
Cited by 2,898
- Verified
4-1BB costimulation ameliorates T cell exhaustion induced by tonic signaling of chimeric antigen receptors
Long, A. H., Haso, W. M., Shern, J. F., Wanhainen, K. M., Murgai, M., Ingaramo, M., Smith, J. P., Walker, A. J., Kohler, M. E., Venkateshwara, V. R., et al. (2015) · Nature Medicine
CAR-T cell therapy researchT-cell and B-cell Immunology
Cited by 1,815
- Verified
Induction of resistance to chimeric antigen receptor T cell therapy by transduction of a single leukemic B cell
Ruella, M., Xu, J., Barrett, D. M., Fraietta, J. A., Reich, T. J., Ambrose, D. E., Klichinsky, M., Shestova, O., Patel, P. R., Kulikovskaya, I., et al. (2018) · Nature Medicine
CAR-T cell therapy researchImmunotherapy and Immune Responses
Cited by 659
- Verified
The many faces of IL-7: from lymphopoiesis to peripheral T cell maintenance
Fry, T. J., & Mackall, C. L. (2005) · The Journal of Immunology
T-cell and B-cell ImmunologyPsoriasis: Treatment and Pathogenesis
Cited by 563
- Verified
IL-7 administration to humans leads to expansion of CD8+ and CD4+ cells but a relative decrease of CD4+ T-regulatory cells
Rosenberg, S. A., Sportès, C., Ahmadzadeh, M., Fry, T. J., Ngo, L. T., Schwarz, S. L., Stetler-Stevenson, M., Morton, K. E., Mavroukakis, S. A., Morre, M., et al. (2006) · Journal of Immunotherapy
T-cell and B-cell ImmunologyHIV Research and Treatment
Cited by 443
- Verified
CD4/CD8 T-cell selection affects chimeric antigen receptor (CAR) T cell potency and toxicity: updated results from a phase I anti-CD22 CAR T cell trial
Shah, N. N., Highfill, S. L., Shalabi, H., Yates, B., Jin, J., Wolters, P. L., Ombrello, A., Steinberg, S. M., Martin, S., Delbrook, C., et al. (2020) · Journal of Clinical Oncology
CAR-T cell therapy researchAcute Lymphoblastic Leukemia research
Cited by 421
- Verified
TCR engagement negatively affects CD8 but not CD4 CAR T cell expansion and leukemic clearance
Yang, Y., Kohler, M. E., Chien, C. D., Sauter, C. T., Jacoby, E., Yan, C., Hu, Y., Wanhainen, K., Qin, H., & Fry, T. J. (2017) · Science Translational Medicine
CAR-T cell therapy researchT-cell and B-cell Immunology
Cited by 208
- Verified
T cells genetically engineered to overcome death signaling enhance adoptive cancer immunotherapy
Yamamoto, T. N., Lee, P.-H., Vodnala, S. K., Gurusamy, D., Kishton, R. J., Yu, Z., Eidizadeh, A., Eil, R., Fioravanti, J., Gattinoni, L., et al. (2019) · Journal of Clinical Investigation
CAR-T cell therapy researchImmunotherapy and Immune Responses
Cited by 156
- Verified
Effect of cryopreservation on autologous chimeric antigen receptor T cell characteristics
Panch, S. R., Srivastava, S. K., Elavia, N., McManus, A., Liu, S., Jin, P., Highfill, S. L., Li, X., Dagur, P., Kochenderfer, J. N., et al. (2019) · Molecular Therapy
CAR-T cell therapy researchImmunotherapy and Immune Responses
Cited by 107
- Verified
Absence of Replication-Competent Lentivirus in the Clinic: Analysis of Infused T Cell Products
Cornetta, K., Duffy, L., Turtle, C. J., Jensen, M., Forman, S., Binder-Scholl, G., Fry, T., Chew, A., Maloney, D. G., & June, C. H. (2018) · Molecular Therapy
Virus-based gene therapy researchCAR-T cell therapy research
Cited by 98
- Verified
Elutriated lymphocytes for manufacturing chimeric antigen receptor T cells
Stroncek, D. F., Lee, D. W., Ren, J., Sabatino, M., Highfill, S., Khuu, H., Shah, N. N., Kaplan, R. N., Fry, T. J., & Mackall, C. L. (2017) · Journal of Translational Medicine
CAR-T cell therapy researchImmunotherapy and Immune Responses
Cited by 80
- Verified
Infectious complications of CAR T-cell therapy across novel antigen targets in the first 30 days
Mikkilineni, L., Yates, B., Steinberg, S. M., Shahani, S. A., Molina, J. C., Palmore, T., Lee, D. W., Kaplan, R. N., Mackall, C. L., Fry, T. J., et al. (2021) · Blood Advances
CAR-T cell therapy researchNeutropenia and Cancer Infections
Cited by 75
- Verified
Recombinant Interleukin-7 Induces Proliferation of Naive Macaque CD4+and CD8+T Cells In Vivo
Moniuszko, M., Fry, T., Tsai, W.-P., Morre, M., Assouline, B., Cortez, P., Lewis, M. G., Cairns, S., Mackall, C., & Franchini, G. (2004) · Journal of Virology
T-cell and B-cell ImmunologyImmunotherapy and Immune Responses
Cited by 74
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free